Paul D Duke Net Worth

The estimated Net Worth of Paul D Duke is at least 9.59 百万$ dollars as of 15 May 2010. Paul Duke owns over 6,500 units of Mesa Laboratories stock worth over 8,886,801$ and over the last 21 years Paul sold MLAB stock worth over 702,990$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Paul Duke MLAB stock SEC Form 4 insiders trading

Paul has made over 13 trades of the Mesa Laboratories stock since 2004, according to the Form 4 filled with the SEC. Most recently Paul exercised 6,500 units of MLAB stock worth 52,845$ on 15 May 2010.

The largest trade Paul's ever made was exercising 19,500 units of Mesa Laboratories stock on 12 January 2006 worth over 91,845$. On average, Paul trades about 3,050 units every 111 days since 2004. As of 15 May 2010 Paul still owns at least 74,323 units of Mesa Laboratories stock.

You can see the complete history of Paul Duke stock trades at the bottom of the page.

What's Paul Duke's mailing address?

Paul's mailing address filed with the SEC is 12100 W 6TH AVENUE, , LAKEWOOD, CO, 80228.

Insiders trading at Mesa Laboratories

Over the last 21 years, insiders at Mesa Laboratories have traded over 50,273,983$ worth of Mesa Laboratories stock and bought 209,660 units worth 5,099,819$ . The most active insiders traders include Mark Christopher Capone、R Tony Tripeny、John James Sullivan. On average, Mesa Laboratories executives and independent directors trade stock every 20 days with the average trade being worth of 430,930$. The most recent stock trade was executed by Gary M Owens on 6 September 2024, trading 3,301 units of MLAB stock currently worth 394,701$.

What does Mesa Laboratories do?

mesa laboratories, inc., develops, manufactures and markets high-quality process validation, monitoring and calibration instruments and consumables worldwide. mesa offers quality data loggers for monitoring temperature, humidity, and pressure and biological indicators (bis) for medical device and pharmaceutical manufacturing sterilization monitoring. the datatrace data loggers and mesa bis are available to monitor and validate applications including steam and eo sterilization, autoclave validation, incubators, heat tunnels and more. mesa’s bi offering also includes bis for industrial use, hydrogen peroxide (h2o2), chlorine dioxide and more. the phoenix meter is a point-of-use dialysate qc meter used prior to each procedure. the 90xl meter is the industry standard for calibration of dialysis machines in the field. also available are industry leading nist-traceable calibration solutions. mesa also offers cap torque testers which are durable, reliable and computerized cap torque analyzers

Complete history of Paul Duke stock trades at Mesa Laboratories

Mesa Laboratories executives and stock owners

Mesa Laboratories executives and other stock owners filed with the SEC include:

• Gary Owens,
  President, Chief Executive Officer, Director
• John Sakys,
  Chief Financial Officer, Executive Vice President, Chief Accounting Officer, Corporate Secretary
• Greg DiNoia,
  Senior Vice President - Commercial Operations
• Gary M. Owens,
  CEO, Pres & Director
• Brian Archbold,
  Senior Vice President - Continuous Improvement
• Brian David Archbold,
  Sr. VP of Continuous Improvement
• John V. Sakys,
  CFO & Chief Accounting Officer
• Gregory T. DiNoia,
  Sr. VP of Commercial Operations
• John Sullivan,
  Chairman of the Board
• John Schmieder,
  Independent Director
• David Kelly,
  Independent Director
• Evan Guillemin,
  Independent Director
• Jennifer Alltoft,
  Independent Director
• Shannon Hall,
  Director
• Peter M. Dansky,
  Pres of Clinical Genomics
• Garrett Krushefski,
  Sr. VP of Operations
• Bryan T. Leo,
  Sr. VP of Operations
• Gina Hinman Trulli,
  VP of HR
• Elizabeth Karpinski Vonne,
  VP of Legal, Gen. Counsel & Sec.
• Robert Bradley,
  Sr. Director of Operations
• Michael T Brooks,
  Director
• H Stuart Campbell,
  Director
• Ventures, Llc Seg,
  Director
• Luke R Schmieder,
  President CEO Treasurer
• Paul D Duke,
  Director
• Michael Tranmer,
  Executive Vice President
• Glenn E Adriance,
  VP Sales and Marketing
• Steven W Peterson,
  VP Finance, CFO, Secretary
• Robert V Dwyer,
  Director
• David Brian Perez,
  Director
• Mark Christopher Capone,
  Director
• Shiraz Shabanali Ladiwala,
  Director
• Laboratories Inc /Co/ Mesa,
  Director
• R Tony Tripeny,
  Director